The domain III fragment of Japanese encephalitis virus envelope protein: Mouse immunogenicity and liposome adjuvanticity

51Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The E protein of Japanese encephalitis virus (JEV) is the major antigen used to elicit neutralizing antibody response and protective immunity in hosts. In this study, the domain III protein of the attenuated strain CH2195LA was cloned to the pET32a expression vector and expressed as a thioredoxin (Trx) fusion protein in Escherichia coli. The recombinant protein was unique in forming a large fraction of the soluble recombinant protein in E. coli. The purified domain III fusion protein (TrxD3) was emulsified in Freund's adjuvant (FA) as well as in different charged liposomes for immunization in mice. Immunization of TrxD3 fusion protein emulsified in Freund's adjuvant and only the cationic liposome resulted in eliciting neutralizing antibodies and protective immunity in ICR mice. The cationic liposome can serve not only as a safer but also an effective adjuvant for the TrxD3 protein immunization. These studies can provide useful information for further developing the domain III recombinant protein vaccine against JEV. © 2003 Elsevier Science Ltd. All rights reserved.

Cite

CITATION STYLE

APA

Wu, S. C., Yu, C. H., Lin, C. W., & Chu, I. M. (2003). The domain III fragment of Japanese encephalitis virus envelope protein: Mouse immunogenicity and liposome adjuvanticity. Vaccine, 21(19–20), 2516–2522. https://doi.org/10.1016/S0264-410X(03)00042-2

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free